NEONC TECHNOLOGIES HOLDINGS, INC. Legal Fees
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Legal Fees of $1.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. legal fees for the quarter ending 2026-06-30 was $1.29M, a 147.17% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. legal fees for the quarter ending 2026-03-31 was $1.19M, a 24.09% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. legal fees for the quarter ending 2025-12-31 was $727.13K, a 16.20% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. legal fees for the quarter ending 2025-09-30 was $276.38K, a 25.89% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. legal fees for fiscal 2025 was $2.48M, a 24.03% increase from fiscal 2024.
- NEONC TECHNOLOGIES HOLDINGS, INC. legal fees for fiscal 2024 was $2.00M.
| Period end | Legal Fees 3 month | Legal Fees 6 month | Legal Fees 9 month | Legal Fees 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.29M 10-Q · filed 2026-08-10 | $2.47M 10-Q · filed 2026-08-10 | $3.20M derived: sum of 3 quarters · filed 2026-08-10 | $3.48M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $1.19M 10-Q · filed 2026-05-15 | $1.92M derived: sum of 2 quarters · filed 2026-05-15 | $2.19M derived: sum of 3 quarters · filed 2026-05-15 | $2.71M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $727.13K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.00M derived: sum of 2 quarters · filed 2026-03-31 | $1.52M derived: sum of 3 quarters · filed 2026-08-10 | $2.48M 10-K · filed 2026-03-31 |
| 2025-09-30 | $276.38K 10-Q · filed 2025-11-14 | $796.74K derived: sum of 2 quarters · filed 2026-08-10 | $1.75M 10-Q · filed 2025-11-14 | $2.38M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $520.36K 10-Q · filed 2026-08-10 | $1.48M 10-Q · filed 2026-08-10 | $2.10M derived: sum of 3 quarters · filed 2026-08-10 | $2.32M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $957.54K 10-Q · filed 2026-05-15 | $1.58M derived: sum of 2 quarters · filed 2026-05-15 | $1.80M derived: sum of 3 quarters · filed 2026-05-15 | $2.39M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $625.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $845.28K derived: sum of 2 quarters · filed 2026-03-31 | $1.44M derived: sum of 3 quarters · filed 2026-03-31 | $2.00M 10-K · filed 2026-03-31 |
| 2024-09-30 | $219.53K 10-Q · filed 2025-11-14 | $810.51K derived: sum of 2 quarters · filed 2025-11-14 | $1.37M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $590.98K 10-Q · filed 2025-08-18 | $1.16M 10-Q · filed 2025-08-18 | ||
| 2024-03-31 | $564.35K 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |